HN
HNL.F Dr. Hönle AG
- Market cap
- EUR 44.9M
- P/E
- -
- P/B
- 0.60x
- ROE
- -1.8%
- Dividend yield
- 0.29%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is HNL.F undervalued?
Graham numberThe Graham number of Dr. Hönle AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dr. Hönle AG fundamental analysis
No fundamental analysis for Dr. Hönle AG yet.
Dr. Hönle AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing …
Full company profileDr. Hönle AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Dr. Hönle AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 93.4M | 102M | 126M | 108M | 93.9M | 115M | 127M | 106M | 98.7M | 93.7M | 92.0M |
| Gross Profit | 59.9M | 65.8M | 85.4M | 72.8M | 60.5M | 69.3M | 62.3M | 53.3M | 58.0M | 58.7M | 59.2M |
| Operating Income | 12.2M | 15.4M | 30.4M | 16.6M | 8.73M | 85.0K | -12.1M | -9.42M | -10.2M | -552K | 1.01M |
| EBITDA | - | 18.2M | 33.9M | 20.3M | 14.9M | 14.0M | 4.46M | 779K | 3.07M | 6.00M | 5.99M |
| Net Income | 8.28M | 10.4M | 21.7M | 12.5M | 5.68M | -4.82M | -13.4M | -11.0M | -13.3M | -3.17M | -1.40M |
| EPS | - | 1.89 | 3.94 | 2.26 | 0.94 | -0.80 | -2.20 | -1.82 | -2.19 | -0.52 | -0.23 |
| Balance Sheet | |||||||||||
| Total Assets | 94.3M | 102M | 126M | 144M | 196M | 203M | 195M | 176M | 155M | 146M | 143M |
| Total Liabilities | 32.6M | 32.5M | 38.3M | 54.0M | 79.5M | 91.8M | 88.2M | 80.0M | 75.7M | 68.5M | 66.6M |
| Shareholders' Equity | 59.9M | 67.9M | 87.1M | 90.0M | 116M | 111M | 107M | 95.8M | 79.4M | 76.9M | 75.9M |
| Cash & Short-term Investments | 6.52M | 5.22M | 12.0M | 14.6M | 34.2M | 12.1M | 7.13M | 9.32M | 7.51M | 7.75M | 7.23M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.63M | 6.58M | 24.2M | 16.9M | 7.23M | 1.13M | -7.41M | 3.14M | 5.53M | 4.99M | 4.41M |
| Capital Expenditure | 4.98M | 5.36M | 10.6M | 19.3M | 30.2M | 17.1M | 4.31M | 2.93M | 2.09M | 1.90M | 1.33M |
| Free Cash Flow | - | 1.22M | 13.6M | -2.35M | -23.0M | -16.0M | -11.7M | 209K | 3.44M | 3.09M | 3.08M |
| Ratios | |||||||||||
| ROE | 13.8% | 15.4% | 25.0% | 13.9% | 4.9% | -4.4% | -12.5% | -11.5% | -16.7% | -4.1% | -1.8% |
| ROA | 8.8% | 10.2% | 17.3% | 8.7% | 2.9% | -2.4% | -6.8% | -6.2% | -8.5% | -2.2% | -1.0% |
| Net Profit Margin | 8.9% | 10.2% | 17.2% | 11.6% | 6.0% | -4.2% | -10.6% | -10.3% | -13.5% | -3.4% | -1.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Dr. Hönle AG dividends
- Dividend yield
- 0.29%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Mar 25, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 128K | 0.02 | - |
| 2024 | EUR 123K | 0.02 | - |
| 2023 | EUR 123K | 0.02 | - |
| 2022 | EUR 1.21M | 0.20 | - |
| 2021 | EUR 3.03M | 0.50 | - |
| 2020 | EUR 4.41M | 0.73 | 77.7% |
| 2019 | EUR 4.41M | 0.80 | 35.3% |
| 2018 | EUR 3.31M | 0.60 | 15.2% |
| 2017 | EUR 3.03M | 0.55 | 29.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Dr. Hönle AG
- Insiders 32.30%
- Institutions 8.81%
- Public & others 58.89%
- Shares outstanding 6.06M
- Free float 4.52M
Dr. Hönle AG company profile
- Company name
- Dr. Hönle AG
- Ticker
- HNL.F
- ISIN
- DE0005157101
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Electrical Equipment
- Employees
- 553
- Fiscal year end
- September
- Address
- Nicolaus-Otto-Str. 2, Gilching, Germany, 82205
- Phone
- 49 8105 2083 0
- Website
- hoenle.de
About Dr. Hönle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing, coating, and printing on three dimensional objects industries. The Disinfection segment is involved in activities in the areas of industrial water, surface, and air disinfection, including microbiological testing for various applications comprising disinfection in food industry, special lamps for life science, custom lamps, and microbiologic analyses. It serves aerospace, automotive, consumer electronics, environmental, food, health and medical technology, print, and semiconductor industries. The company was formerly known as Dr. Hönle AG and changed its name to Hoenle AG. The company was founded in 1976 and is headquartered in Gilching, Germany.
Dr. Hönle AG management
3- Dr. Franz RichterCEO & Chairman of the Management Board · born 1955
- Mr. Robert StarkCFO & Member of Management Board · born 1991
- Mr. Peter WeinertHead of Investor Relations